Article Versions Notes

Abdelzaher WY, De Waard M, Abdelmonaem AA, Ali DM, El-Tahawy NFG, Rifaai RA, Mohamed HA, Shaheen K, Zeen El-Din MA, Welson NN, et al. Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity. Pharmaceuticals. 2023; 16(2):168. https://doi.org/10.3390/ph16020168

Abdelzaher, Walaa Yehia, Michel De Waard, Alyaa Abdelfattah Abdelmonaem, Dalia Mohamed Ali, Nashwa Fathy Gamal El-Tahawy, Rehab Ahmed Rifaai, Hatem A. Mohamed, Kareem Shaheen, Mohamed Ahmed Zeen El-Din, Nermeen N. Welson, and et al. 2023. "Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity" Pharmaceuticals 16, no. 2: 168. https://doi.org/10.3390/ph16020168

Abdelzaher, W. Y., De Waard, M., Abdelmonaem, A. A., Ali, D. M., El-Tahawy, N. F. G., Rifaai, R. A., Mohamed, H. A., Shaheen, K., Zeen El-Din, M. A., Welson, N. N., Tawfeek, S. E., Batiha, G. E.-S., & Abdel-Aziz, A. M. (2023). Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity. Pharmaceuticals, 16(2), 168. https://doi.org/10.3390/ph16020168